We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated PCR Home-Test Device Accurately Detects Covid-19 in Saliva

By LabMedica International staff writers
Posted on 04 Aug 2022
Print article
Image: The SLIDE device analyzes saliva and could help make COVID-19 testing quicker and easier (Photo courtesy of Dr. Weihua Guan, Pennsylvania State University)
Image: The SLIDE device analyzes saliva and could help make COVID-19 testing quicker and easier (Photo courtesy of Dr. Weihua Guan, Pennsylvania State University)

A recently developed saliva-based Covid-19 home test combines the simplicity and speed of rapid antigen tests with the accuracy of the gold-standard RT-PCR method.

Rapid antigen tests for the SARS-CoV-2 (Covid-19) antigen from nasal samples provide a fast (15 minutes) result. However, the sensitivity of antigen tests is 30 to 40% lower than nucleic acid testing (PCR), which could miss a significant portion of infected patients.

With the problem of low sensitivity in mind, investigators at Pennsylvania State University (University Park, PA, USA) developed a fully integrated SARS-CoV-2 reverse transcription loop-mediated isothermal amplification (RT-LAMP) device (SLIDE) using a self-collected saliva sample. The five distinct modules of the SLIDE platform conducted all of the steps needed for RT-LAMP: heating the sample, mixing it with RT-LAMP reagents, carrying out the reaction, detecting how much viral RNA was present, and communicating that result to a smartphone.

The individual using the SLIDE platform simply projects saliva into a vial and onto a cartridge that is inserted into the device, and results are sent to a smartphone within 45 minutes.

The investigators reported that the SLIDE device achieved the limit of detection (LoD) of five copies/microliter of the saliva sample, which is comparable with the LoD (six copies/microliter) using FDA-approved quantitative real-time polymerase chain reaction (qRT-PCR) assays with the same heat-lysis saliva sample preparation method. With clinical samples, the SLIDE platform showed a good agreement with the results from the gold-standard RT-PCR method.

The investigators proposed that the SLIDE platform had great potential for performing self-administrated SARS-CoV-2 nucleic acid testing at home with noninvasive saliva samples.

The SLIDE device was described in the August 3, 2022, online edition of the journal ACS Sensors.

Related Links:
Pennsylvania State University 

 

Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.